Utility of genetic variants to predict prognosis in coronary artery disease patients receiving statin treatment.
Authors:
- 1 August 2017
- journal article
- Vol. 10 (8) , 8795-8803
Abstract
Statins are widely used drugs for lowering low-density lipoprotein cholesterol (LDL-C) and can prevent cardiovascular events. This study aimed to evaluate the influence of single nucleotide polymorphisms (SNPs) and their cumulative effects on the prognosis of coronary artery disease (CAD) patients treated with statins. Sixteen SNPs were genotyped in 785 CAD patients receiving statin therapy, and their associations with clinical features and prognosis of patients were investigated. Four SNPs (rs2296651, rs11206510, rs8192870, and rs1801133) were significantly associated with complications of CAD (P<0.05). Four SNPs (rs8192870, rs4149056, rs12916, and rs2231142) affected blood lipid levels (P<0.05). Furthermore, rs1801133 showed a weak but significant association with fasting plasma glucose (P = 0.033). Survival analyses showed that rs11206510 (adjusted HR = 1.891, 95% CI: 1.188-3.010, P = 0.007) and rs1801133 (adjusted HR = 1.499, 95% CI: 1.141-1.971, P = 0.004) were independently associated with an increased risk of major cardiovascular events, and exhibited cumulative effect on even-free survival (adjusted HR = 1.810, 95% CI: 1.179-2.802, P = 0.007). In conclusion, rs11206510 and rs1801133 were independent risk factors for clinical outcome in CAD patients treated with statins.Keywords
This publication has 46 references indexed in Scilit:
- Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?European Journal of Clinical Pharmacology, 2015
- Function-impairing polymorphisms of the hepatic uptake transporter SLCO1B1 modify the therapeutic efficacy of statins in a population-based cohortPharmacogenetics and Genomics, 2015
- LDL‐c‐linked SNPs are associated with LDL‐c and myocardial infarction despite lipid‐lowering therapy in patients with established vascular diseaseEuropean Journal of Clinical Investigation, 2013
- Association between the ABCG2 C421A polymorphism and Alzheimer's diseaseNeuroscience Letters, 2013
- Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patientsJournal of Gastroenterology, 2013
- Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemiaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to RosuvastatinClinical Pharmacology & Therapeutics, 2010
- Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical EffectsJournal of Clinical Oncology, 2009
- Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and RosuvastatinClinical Pharmacology & Therapeutics, 2007
- Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapyCurrent Opinion in Lipidology, 2007